321 related articles for article (PubMed ID: 23204989)
1. Prevention and Treatment of Cardiovascular Disease in Adolescents and Adults through the Transcendental Meditation(®) Program: A Research Review Update.
Barnes VA; Orme-Johnson DW
Curr Hypertens Rev; 2012 Aug; 8(3):227-242. PubMed ID: 23204989
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Pre-clinical Applications of the Transcendental Meditation Program in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults.
Barnes VA; Orme-Johnson DW
Curr Hypertens Rev; 2006 Aug; 2(3):207-218. PubMed ID: 22383899
[TBL] [Abstract][Full Text] [Related]
3. Stress Reduction in the Prevention of Left Ventricular Hypertrophy: A Randomized Controlled Trial of Transcendental Meditation and Health Education in Hypertensive African Americans.
Schneider RH; Myers HF; Marwaha K; Rainforth MA; Salerno JW; Nidich SI; Gaylord-King C; Alexander CN; Norris KC
Ethn Dis; 2019; 29(4):577-586. PubMed ID: 31641325
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial stress and cardiovascular disease. Part 3: Clinical and policy implications of research on the transcendental meditation program.
Walton KG; Schneider RH; Salerno JW; Nidich SI
Behav Med; 2005; 30(4):173-83. PubMed ID: 15981895
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial stress and cardiovascular disease Part 2: effectiveness of the Transcendental Meditation program in treatment and prevention.
Walton KG; Schneider RH; Nidich SI; Salerno JW; Nordstrom CK; Bairey Merz CN
Behav Med; 2002; 28(3):106-23. PubMed ID: 16463759
[TBL] [Abstract][Full Text] [Related]
6. Review of controlled research on the transcendental meditation program and cardiovascular disease. Risk factors, morbidity, and mortality.
Walton KG; Schneider RH; Nidich S
Cardiol Rev; 2004; 12(5):262-6. PubMed ID: 15316306
[TBL] [Abstract][Full Text] [Related]
7. A controlled study of the effects of the Transcendental Meditation program on cardiovascular reactivity and ambulatory blood pressure.
Wenneberg SR; Schneider RH; Walton KG; Maclean CR; Levitsky DK; Salerno JW; Wallace RK; Mandarino JV; Rainforth MV; Waziri R
Int J Neurosci; 1997 Jan; 89(1-2):15-28. PubMed ID: 9134445
[TBL] [Abstract][Full Text] [Related]
8. Transcendental meditation, hypertension and heart disease.
King MS; Carr T; D'Cruz C
Aust Fam Physician; 2002 Feb; 31(2):164-8. PubMed ID: 11917830
[TBL] [Abstract][Full Text] [Related]
9. Impact of Transcendental Meditation on cardiovascular function at rest and during acute stress in adolescents with high normal blood pressure.
Barnes VA; Treiber FA; Davis H
J Psychosom Res; 2001 Oct; 51(4):597-605. PubMed ID: 11595248
[TBL] [Abstract][Full Text] [Related]
10. The impact of transcendental meditation on depressive symptoms and blood pressure in adults with cardiovascular disease: A systematic review and meta-analysis.
Gathright EC; Salmoirago-Blotcher E; DeCosta J; Balletto BL; Donahue ML; Feulner MM; Cruess DG; Wing RR; Carey MP; Scott-Sheldon LAJ
Complement Ther Med; 2019 Oct; 46():172-179. PubMed ID: 31519275
[TBL] [Abstract][Full Text] [Related]
11. Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans.
Castillo-Richmond A; Schneider RH; Alexander CN; Cook R; Myers H; Nidich S; Haney C; Rainforth M; Salerno J
Stroke; 2000 Mar; 31(3):568-73. PubMed ID: 10700487
[TBL] [Abstract][Full Text] [Related]
12. Stress reduction in the secondary prevention of cardiovascular disease: randomized, controlled trial of transcendental meditation and health education in Blacks.
Schneider RH; Grim CE; Rainforth MV; Kotchen T; Nidich SI; Gaylord-King C; Salerno JW; Kotchen JM; Alexander CN
Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):750-8. PubMed ID: 23149426
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure response to transcendental meditation: a meta-analysis.
Anderson JW; Liu C; Kryscio RJ
Am J Hypertens; 2008 Mar; 21(3):310-6. PubMed ID: 18311126
[TBL] [Abstract][Full Text] [Related]
14. Transcendental meditation for the primary prevention of cardiovascular disease.
Hartley L; Mavrodaris A; Flowers N; Ernst E; Rees K
Cochrane Database Syst Rev; 2014; (12):CD010359. PubMed ID: 25436436
[TBL] [Abstract][Full Text] [Related]
15. Transcendental Meditation in the prevention and treatment of cardiovascular disease and pathophysiological mechanisms: An evidence-based review.
Schneider RH; Carr T
Adv Integr Med; 2014 Dec; 1(3):107-112. PubMed ID: 35813238
[TBL] [Abstract][Full Text] [Related]
16. Trials of Maharishi Ayurveda for cardiovascular disease: A pooled analysis of outcome studies with carotid intima-media thickness.
Walton KG; Olshansky B; Helene E; Schneider RH
J Preventive Cardiol; 2014 Aug; 4(1):615-623. PubMed ID: 35756148
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease prevention and health promotion with the transcendental meditation program and Maharishi consciousness-based health care.
Schneider RH; Walton KG; Salerno JW; Nidich SI
Ethn Dis; 2006; 16(3 Suppl 4):S4-15-26. PubMed ID: 16938913
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of stress reduction on mortality in persons > or = 55 years of age with systemic hypertension.
Schneider RH; Alexander CN; Staggers F; Rainforth M; Salerno JW; Hartz A; Arndt S; Barnes VA; Nidich SI
Am J Cardiol; 2005 May; 95(9):1060-4. PubMed ID: 15842971
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for stress management in reducing hypertension in African Americans?
Kondwani KA; Lollis CM
Ethn Dis; 2001; 11(4):788-92. PubMed ID: 11763303
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological correlates of higher states of consciousness during sleep in long-term practitioners of the Transcendental Meditation program.
Mason LI; Alexander CN; Travis FT; Marsh G; Orme-Johnson DW; Gackenbach J; Mason DC; Rainforth M; Walton KG
Sleep; 1997 Feb; 20(2):102-10. PubMed ID: 9143069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
